https://www.selleckchem.com/Bcl-2.html and triaging high-risk patients. Solitary fibrous tumor (SFT), a fibroblastic neoplasm characterized by a specific genetic alteration (NAB2-STAT6 fusion) and relatively specific immunohistochemical profile (STAT6/CD34 positivity), is seldom the subject of cytopathology data. We report our experience with scrape smears and fine-needle aspiration (FNA) biopsies of SFT in a large patient cohort. A search was made of our cytopathology and surgical pathology databases for cases diagnosed as solitary fibrous tumor (SFT). FNA biopsy smears, imprint smears, and cell blocks were performed and examined using standard technique. Thirty-four cases from 30 patients (MF = 1.11; age range 24-86 years, x = 58 years) met inclusion criteria for this study. All patients had prior or subsequent tissue confirmation of SFT. Twenty-seven (79%) specimens were FNAs, and 7 (21%) were scrape smears. Most cases (29, 85%) represented primary tumors, 4 (12%) were metastatic deposits, and 1 (3.5%) was a locally recurrent neoplasm. Sites included pleura/lung 9 (26%), other IHC markers. To analyze the association between public health expenditure per capita and the mortality rate due to COVID-19 in Europe and Spain. Pearson's correlation coefficient was used to compare and contrast the mortality rate due to COVID-19 between countries and autonomous communities with higher and lower public health expenditure per capita than the mean. No correlation between the public health expenditure per capita and the mortality rate due to COVID-19 (r 0.3; p=0.14) was found among European countries or Spain's Autonomous Communities (r 0.03; p=0.91). No significant differences were found when comparing the mortality rate due to COVID-19 among the public health expenditure per capita groups. The available evidence does not support association between «low» public healthcare expenditure and the poor outcomes observed in Spain during the COVID-19 pandemic. Increased funding for